experspadmin

Preclinical Rheumatoid Arthritis and the Potential for Prevention
Rheumatology

Preclinical Rheumatoid Arthritis and the Potential for Prevention

expert roundtables
By Eric M. Ruderman, MD; Jeffrey R. Curtis, MD, MS, MPH; Leonard H. Calabrese, DO
Treatment Advances in Rheumatoid Arthritis
Rheumatology

Treatment Advances in Rheumatoid Arthritis

expert roundtables
By Eric M. Ruderman, MD; Jeffrey R. Curtis, MD, MS, MPH; Leonard H. Calabrese, DO
Biosimilars for Rheumatoid Arthritis: Do Patients Save Money?
Rheumatology

Biosimilars for Rheumatoid Arthritis: Do Patients Save Money?

patient care perspectives
By Jeffrey R. Curtis, MD, MS, MPH
Rheumatoid Arthritis Treatments and Skin Cancer Risk
Rheumatology

Rheumatoid Arthritis Treatments and Skin Cancer Risk

patient care perspectives
By Eric M. Ruderman, MD
Long-term Treatment of Patients With Rheumatoid Arthritis and Cardiovascular Comorbidity
Rheumatology

Long-term Treatment of Patients With Rheumatoid Arthritis and Cardiovascular Comorbidity

clinical topic updates
By Jeffrey R. Curtis, MD, MS, MPH
Load More